RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 1,390 filers reported holding RAYTHEON CO in Q1 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $492,000 | +18.8% | 2,700 | 0.0% | 0.42% | +11.5% |
| Q4 2018 | $414,000 | -25.8% | 2,700 | 0.0% | 0.37% | -16.7% |
| Q3 2018 | $558,000 | +6.9% | 2,700 | 0.0% | 0.45% | +4.9% |
| Q2 2018 | $522,000 | -10.5% | 2,700 | 0.0% | 0.43% | -13.7% |
| Q1 2018 | $583,000 | +15.0% | 2,700 | 0.0% | 0.50% | +18.4% |
| Q4 2017 | $507,000 | +0.6% | 2,700 | 0.0% | 0.42% | -0.7% |
| Q3 2017 | $504,000 | +15.6% | 2,700 | 0.0% | 0.42% | +11.9% |
| Q2 2017 | $436,000 | +5.8% | 2,700 | 0.0% | 0.38% | +3.6% |
| Q1 2017 | $412,000 | +7.6% | 2,700 | 0.0% | 0.36% | +3.1% |
| Q4 2016 | $383,000 | +4.1% | 2,700 | 0.0% | 0.35% | +1.7% |
| Q3 2016 | $368,000 | +0.3% | 2,700 | 0.0% | 0.35% | -3.6% |
| Q2 2016 | $367,000 | +10.9% | 2,700 | 0.0% | 0.36% | -6.5% |
| Q1 2016 | $331,000 | -1.5% | 2,700 | 0.0% | 0.38% | +2.4% |
| Q4 2015 | $336,000 | +13.9% | 2,700 | 0.0% | 0.38% | +15.3% |
| Q3 2015 | $295,000 | +14.3% | 2,700 | 0.0% | 0.33% | +29.4% |
| Q2 2015 | $258,000 | -12.5% | 2,700 | 0.0% | 0.25% | -8.7% |
| Q1 2015 | $295,000 | +1.0% | 2,700 | 0.0% | 0.28% | +4.2% |
| Q4 2014 | $292,000 | +6.6% | 2,700 | 0.0% | 0.26% | -3.3% |
| Q3 2014 | $274,000 | +10.0% | 2,700 | 0.0% | 0.27% | +18.1% |
| Q2 2014 | $249,000 | -6.7% | 2,700 | 0.0% | 0.23% | -9.7% |
| Q1 2014 | $267,000 | +9.0% | 2,700 | 0.0% | 0.26% | +11.3% |
| Q4 2013 | $245,000 | +17.8% | 2,700 | 0.0% | 0.23% | +8.5% |
| Q3 2013 | $208,000 | – | 2,700 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
| Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
| PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
| Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |